Lenz Therapeutics 12-month price target cut to $22
A FactSet-supplied update says Lenz Therapeutics’ 12-month price target was cut to $22, implying a higher upside versus the current price level shown in the headline.
A FactSet-supplied update says Lenz Therapeutics’ 12-month price target was cut to $22, implying a higher upside versus the current price level shown in the headline.